Toronto, Canada

Mona L Gauthier

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Prelude Corporation, University of California. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Mona L Gauthier in Cancer Detection

Introduction

Mona L Gauthier is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of cancer research, particularly in the detection of pre-cancerous conditions. Her work focuses on developing methods that enhance the early detection of cancer, which is crucial for effective treatment and patient outcomes.

Latest Patents

Mona L Gauthier holds 1 patent for her invention titled "Cancer biomarkers and methods of use thereof." This patent provides detection methods for identifying a pre-cancerous epithelial cell signature. The invention also includes reagents that are useful in these detection methods. The subject detection method is applicable in various imaging, diagnostic, prognostic, and patient monitoring methods, which are also part of her innovative contributions.

Career Highlights

Throughout her career, Gauthier has worked with prestigious institutions, including the University of California and Prelude Corporation. Her experience in these organizations has allowed her to collaborate with leading experts in the field of cancer research.

Collaborations

Mona has collaborated with notable professionals such as Thea D Tlsty and Hal K Berman. These collaborations have further enriched her research and contributed to advancements in cancer detection methodologies.

Conclusion

Mona L Gauthier's innovative work in cancer detection exemplifies the importance of early diagnosis in improving patient care. Her contributions to the field are invaluable and continue to inspire future research in cancer biomarkers.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…